Skip to main content
. 2014 Sep 2;19(9):13587–13602. doi: 10.3390/molecules190913587

Figure 4.

Figure 4

(A) ACE inhibitory activity of VKP with IC50 of 1.3 μM. (B) ACE inhibitory activity of VKCFR with IC50 of 34.5 μM. (C) Interface overview of optimal docking positions of VKP at the ACE catalytic site. (D) Interface overview of optimal docking positions of VKCFR at the ACE catalytic site.